Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07072975

CPOD Patient's Tolerance of Intermittent Exercise With Inter-exercise Recovery Under Normoxic Hypoxia

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Centre Hospitalier Universitaire, Amiens · Academic / Other
Sex
All
Age
40 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Exercise retraining improves the prognosis and quality of life of patients with chronic lung or circulatory diseases. However, exercise intolerance may be caused by excessive ventilatory. Exposure to oxygen-replete air reduces this ventilatory overload, improves sleep and enhances responses to exercise. This study examine the impact of the acute manipulation of oxygen availability during inter-exercise recovery period of an intermittent cycling exercise on perceptual responses. this randomized, controlled, study include adult patient with COPD. On separate days, 50 patients with COPD completed four sets of 4-min at 85% of VO2peak intercept by 3-min of passive recovery in two randomized between-sets recovery conditions. Rating exertion perception, gaz exchanges, heart rate, sleep quality and nocturnal heart rate variability were assessed. Hypoxic exposure during inter-repetition recovery phases would reduce the ventilatory load during exercise. What's more, patients would not be forced to perform the sporting gesture in a restricted space or wearing a mask, limiting dyspnea and the perceived difficulty of the effort. Lastly, the induction of hypoxic stress during the re-training session helped to improve patients' sleep.

Conditions

Interventions

TypeNameDescription
OTHERNormobaric hypoxiaNormobaric hypoxia (inspired oxygen fraction of 12.9%) applied between-sets recovery periods
OTHERnormoxic conditionBetween-sets recovery periods under normoxic condition

Timeline

Start date
2025-10-01
Primary completion
2027-07-01
Completion
2027-08-01
First posted
2025-07-18
Last updated
2025-10-01

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07072975. Inclusion in this directory is not an endorsement.